Zobrazeno 1 - 4
of 4
pro vyhledávání: '"G A Aleskerova"'
Autor:
T T Valiev, A S Levashov, N A Batmanova, E R Senzhapova, K A Turupaev, U V Tomchik, G A Aleskerova
Publikováno v:
Современная онкология, Vol 19, Iss 2, Pp 54-60 (2017)
Actually targeted drugs became a therapeutic component for adult patients with malignancies and merge into clinical therapeutic recommendations. Targeted drugs in pediatric oncology had been using for 10-15 years and this experience under systematiza
Externí odkaz:
https://doaj.org/article/9eb79e9bc7a94a898c85cb6945cc8f60
Autor:
T. T. Valiev, M. A. Shervashidze, I. V. Osipova, T. I. Burlutskaya, N. A. Popova, N. S. Osmulskaya, G. A. Aleskerova, S. L. Sabantsev, Z. S. Gordeeva, V. Yu. Smirnov, O. A. Poberezhnaya, S. N. Yuldasheva, I. A. Babich, V. T. Guseynov, S. N. Jalilova, Yu. S. Korkina, N. A. Batmanova, K. I. Kirgizov, S. R. Varfolomeeva
Publikováno v:
Russian Journal of Pediatric Hematology and Oncology. 9:32-41
Background. Recovery of children with acute lymphoblastic leukemia (ALL) was one of the most significant achievements of clinical oncohematology of XX century. Success in the treatment of ALL became possible due to comprehensive (clinical, morphoimmu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::541003d62ac30088f80ab46e896125f8
https://doi.org/10.21682/2311-1267-2022-9-3-32-41
https://doi.org/10.21682/2311-1267-2022-9-3-32-41
Autor:
G. A. Aleskerova
Publikováno v:
Медицинский совет, Vol 1, Iss 1, Pp 172-178 (2016)
The article tells about the main stages of improving treatment regimens for acute lymphoblastic leukemia (ALL) in children, from monotherapy with prednisolone and 6-mercaptopurine to novel multicomponent risk-adapted chemotherapy protocols. The focus
Externí odkaz:
https://doaj.org/article/974b4c9c26c347db87240e3bffd50970
Autor:
A.S. Levashov, N A Batmanova, G A Aleskerova, T T Valiev, K A Turupaev, E.R. Senzhapova, U V Tomchik
Publikováno v:
Современная онкология, Vol 19, Iss 2, Pp 54-60 (2017)
Actually targeted drugs became a therapeutic component for adult patients with malignancies and merge into clinical therapeutic recommendations. Targeted drugs in pediatric oncology had been using for 10-15 years and this experience under systematiza
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f0e5e1b611c03d0fa533984ac58830d
https://doi.org/10.26442/1815-1434_19.2.54-60
https://doi.org/10.26442/1815-1434_19.2.54-60